A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. - Wikidata - wikimedia - TriplyDB

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q37031963

about

Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.Studies of the Pelger-Huët anomaly in foxhounds.Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease.Studies of immune functions of patients with systemic lupus erythematosus: antibodies to desialized, rather than intact, T cells preferentially bind to and eliminate suppressor effector T cells Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets

P2860

Q33553860-C0D7CCC2-7FCC-4783-924F-C64A7BE7D6AD Q36093040-4E6A6ED6-527C-414B-B162-698DB2924F79 Q36783964-953F6736-22D6-467F-B4F4-582184DE76FD Q36982582-B296EF6A-B3AF-4253-8C9B-06C194B88A23 Q36996129-C0B76D27-E461-4E05-8840-93D5BC03FDFD Q37017080-146E3765-D408-41A6-A072-44C96A889AB9 Q37020805-9A5261C8-2383-4DF2-87C1-145805EFA8B8 Q37021256-0AC0CB54-9164-4958-A0B8-3DF45550E6B4 Q37036829-F0C4E98D-A8E6-4CBC-9E3B-C80296FF3B18 Q37038182-DE89779B-263B-4ADC-8072-996F7DDE96D2 Q39573126-32CB16A5-14B7-471C-B9B6-6D2B648F6B06

P2860

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q37031963

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 1978

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@en

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@nl

type

label

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@en

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@nl

prefLabel

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@en

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@nl

P1433

Q37031963-E38A6FEF-1462-457C-AC87-AA8185D8AE4B

P1476

Q37031963-D15802EE-7024-4BEB-8E05-878ECB5B43DA

P2093

Q37031963-6AEA54A7-56A5-469A-92A9-2237433518B6

Q37031963-BAEC1ECB-8C3E-4A20-8B51-A10D8E6AAE65

Q37031963-ED8506BD-6806-452E-B8B5-06F173B01600

P2860

Q37031963-045671C1-B52F-4F00-9722-C8C984252769

Q37031963-2839A102-EC2B-407E-901F-59C8A0FA2D07

Q37031963-40938EF1-5A67-4F6E-BA43-EBFDA39E5DF3

Q37031963-5D891ED7-0DFD-4242-9DEB-77A3D27B474A

Q37031963-7D065F58-06BC-45E8-9538-99EEBFCD88AC

Q37031963-9D32CAD4-029E-48D2-A54D-6FDE469BD2C2

Q37031963-C2A7039F-91EF-4D56-8E1B-B5D9C97EAD75

Q37031963-D0E23EB2-E38C-4E83-BB2D-A7F25C06038D

Q37031963-D2987B45-101A-4112-8E01-330E2084D0D9

Q37031963-D29D4DE8-5586-441D-91B2-31D598A9BC95

P304

Q37031963-7862CB35-2DD4-4A2F-9565-6BB733B673F8

P31

Q37031963-D8E31C5A-C47D-4350-AD97-BF5C96AD5206

P356

Q37031963-EE129783-C7A3-4687-BDA2-E3F23B6EBE78

P407

Q37031963-27399CC3-9184-449E-91A2-36830665851A

P433

Q37031963-8D0F42D1-1740-4C91-AF68-4886A828DE75

P478

Q37031963-D507204F-A8A4-431E-9205-F5E0B144D2E8

P577

Q37031963-87232721-5A00-4E68-B3AB-9893FD20BD0B

P5875

Q37031963-5307B5A1-2E17-4A0B-B35F-8195164CAAEE

P698

Q37031963-31FFC34E-C8ED-45E2-AECE-0F44492CF0BA

P921

Q37031963-183D927B-1B44-4CDB-B458-FD0E30825962

P932

Q37031963-4D7ABC1C-A367-4732-B89B-57D4F3B5C3D2

P356

P1433

Journal of Clinical Investigation

P1476

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

@en

P2093

Laughter AH

http://www.w3.org/2001/XMLSchema#string

Steinberg AD

http://www.w3.org/2001/XMLSchema#string

Twomey JJ

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE

Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Immunoregulation and autoimmunity.

Selective loss of suppressor cell function in New Zealand mice induced by NTA.

Lymphocyte-dependent antibody-mediated cytolysis of DNA-anti-DNA-coated target cells using human and murine SLE effector populations.

Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes.

Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.

P304

713-715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI109180

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

1978-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

22828020

http://www.w3.org/2001/XMLSchema#string

P698

308514

http://www.w3.org/2001/XMLSchema#string

P921

P932

371819

http://www.w3.org/2001/XMLSchema#string